Orio Therapeutics is a biotechnology research company that offers treatment and medication support for patients with myocardial infarction.
Orio Therapeutics has raised $118K in total funding. The most recent round was Convertible Note. The last funding was announced in September 2024.
Orio Therapeutics's investors include Venture Kick, Kickfund.
Orio Therapeutics is headquartered in Monthey, Switzerland.
Orio Therapeutics is a biotechnology research company that offers treatment and medication support for patients with myocardial infarction.
Orio Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orio Therapeutics — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/orio-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Orio Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/orio-therapeutics
{{cite web |title=Orio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orio-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated